UPDATE 1-AstraZeneca gets pipeline boost from good gout drug results
August 13, 2014 at 03:20 AM EDT
LONDON, Aug 13 (Reuters) - AstraZeneca, which fended off a $118 billion takeover approach from Pfizer in May, reported positive results for an experimental gout drug on Wednesday that could boost its sales modestly.
